Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Soonchunhyang Institute of Medi-bio Science, Soonchunhyang University, Cheonan 31151, Korea.
Mol Cells. 2018 Mar 31;41(3):168-178. doi: 10.14348/molcells.2018.0008. Epub 2018 Mar 20.
Intracellular communication via ubiquitin (Ub) signaling impacts all aspects of cell biology and regulates pathways critical to human development and viability; therefore aberrations or defects in Ub signaling can contribute to the pathogenesis of human diseases. Ubiquitination consists of the addition of Ub to a substrate protein via coordinated action of E1-activating, E2-conjugating and E3-ligating enzymes. Approximately 40 E2s have been identified in humans, and most are thought to be involved in Ub transfer; although little information is available regarding the majority of them, emerging evidence has highlighted their importance to human health and disease. In this review, we focus on recent insights into the pathogenetic roles of E2s (particularly the ubiquitin-conjugating enzyme E2O [UBE2O]) in debilitating diseases and cancer, and discuss the tantalizing prospect that E2s may someday serve as potential therapeutic targets for human diseases.
细胞内通过泛素 (Ub) 信号的通讯影响细胞生物学的各个方面,并调节对人类发育和生存至关重要的途径;因此 Ub 信号的异常或缺陷可能导致人类疾病的发病机制。泛素化包括通过 E1 激活酶、E2 连接酶和 E3 连接酶的协调作用将 Ub 添加到底物蛋白上。在人类中已经鉴定出大约 40 种 E2s,大多数被认为参与 Ub 转移;尽管大多数 E2s 的信息很少,但新出现的证据强调了它们对人类健康和疾病的重要性。在这篇综述中,我们重点介绍了 E2s(特别是泛素结合酶 E2O [UBE2O])在使人衰弱的疾病和癌症中的发病机制作用的最新见解,并讨论了一个诱人的前景,即 E2s 有朝一日可能成为人类疾病的潜在治疗靶点。